TMO
Thermo Fisher Scientific Inc.
- Total liabilities, 2025
- $56.8B
- YoY, 2025
- +19.2%
- 5-year CAGR
- +10.5%
- 10-year CAGR
- +11.3%
Total liabilities
Total liabilities by fiscal year
| Period | Total liabilities | YoY |
|---|---|---|
| 2025 | $56.8B | +19.2% |
| 2024 | $47.7B | −8.2% |
| 2023 | $51.9B | −2.1% |
| 2022 | $53.0B | −2.1% |
| 2021 | $54.1B | +56.8% |
| 2020 | $34.5B | +20.3% |
| 2019 | $28.7B | +0.2% |
| 2018 | $28.6B | −8.4% |
| 2017 | $31.3B | +28.3% |
| 2016 | $24.4B | +25.1% |
| 2015 | $19.5B | −12.6% |
| 2014 | $22.3B | +48.6% |
| 2013 | $15.0B | +25.3% |
| 2012 | $12.0B | +1.6% |
| 2011 | $11.8B | +97.0% |
| 2010 | $6.0B | −3.3% |
| 2009 | $6.2B | +0.5% |
| 2008 | $6.2B | — |